These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
430 related items for PubMed ID: 18805579
1. Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome. Bercovich D, Ganmore I, Scott LM, Wainreb G, Birger Y, Elimelech A, Shochat C, Cazzaniga G, Biondi A, Basso G, Cario G, Schrappe M, Stanulla M, Strehl S, Haas OA, Mann G, Binder V, Borkhardt A, Kempski H, Trka J, Bielorei B, Avigad S, Stark B, Smith O, Dastugue N, Bourquin JP, Tal NB, Green AR, Izraeli S. Lancet; 2008 Oct 25; 372(9648):1484-92. PubMed ID: 18805579 [Abstract] [Full Text] [Related]
2. Specific JAK2 mutation (JAK2R683) and multiple gene deletions in Down syndrome acute lymphoblastic leukemia. Kearney L, Gonzalez De Castro D, Yeung J, Procter J, Horsley SW, Eguchi-Ishimae M, Bateman CM, Anderson K, Chaplin T, Young BD, Harrison CJ, Kempski H, So CW, Ford AM, Greaves M. Blood; 2009 Jan 15; 113(3):646-8. PubMed ID: 18927438 [Abstract] [Full Text] [Related]
5. Prevalence and clinical correlates of JAK2 mutations in Down syndrome acute lymphoblastic leukaemia. Gaikwad A, Rye CL, Devidas M, Heerema NA, Carroll AJ, Izraeli S, Plon SE, Basso G, Pession A, Rabin KR. Br J Haematol; 2009 Mar 15; 144(6):930-2. PubMed ID: 19120350 [Abstract] [Full Text] [Related]
7. Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group. Hertzberg L, Vendramini E, Ganmore I, Cazzaniga G, Schmitz M, Chalker J, Shiloh R, Iacobucci I, Shochat C, Zeligson S, Cario G, Stanulla M, Strehl S, Russell LJ, Harrison CJ, Bornhauser B, Yoda A, Rechavi G, Bercovich D, Borkhardt A, Kempski H, te Kronnie G, Bourquin JP, Domany E, Izraeli S. Blood; 2010 Feb 04; 115(5):1006-17. PubMed ID: 19965641 [Abstract] [Full Text] [Related]
12. Risks of leukaemia and solid tumours in individuals with Down's syndrome. Hasle H, Clemmensen IH, Mikkelsen M. Lancet; 2000 Jan 15; 355(9199):165-9. PubMed ID: 10675114 [Abstract] [Full Text] [Related]
13. A novel somatic JAK2 kinase-domain mutation in pediatric acute lymphoblastic leukemia with rapid on-treatment development of LOH. Sadras T, Heatley SL, Kok CH, McClure BJ, Yeung D, Hughes TP, Sutton R, Ziegler DS, White DL. Cancer Genet; 2017 Oct 15; 216-217():86-90. PubMed ID: 29025600 [Abstract] [Full Text] [Related]